Keywords: bayer, takes, riociguat, into, phase, iii, germany-based

Bayer takes riociguat into Phase III

Article | 16 February 2009

Print This

Germany-based Bayer Schering Pharma has begun two Phase III trials with its oral, soluble guanylate cyclase agent riociguat in the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in